Dr. Jeremy Koenig

Dr. Jeremy Koenig is a seasoned professional with extensive experience in business development, strategy, and performance architecture. Currently serving as the Business Development and Strategy lead at Sequencing since August 2022, Dr. Koenig also holds the position of Performance Architect at Iris Infinity and is the Founder and CEO of Athletigen, a company focused on performance genomics. Previous roles include Chief Technical Officer at Performance Genomics Inc., Professor and Department Chair at Mount Saint Vincent University, and Postdoctoral Fellow at Cornell University. Dr. Koenig's educational background includes a PhD in Biochemistry and Molecular Biology from Dalhousie University and a postgraduate degree in Molecular Genetics from Cornell University.